0001193125-19-262771 Sample Contracts

OYSTER POINT PHARMA, INC. INDEMNIFICATION AGREEMENT

Indemnification Agreement • October 4th, 2019 • Oyster Point Pharma, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Indemnification Agreement
• Filed
  October 4th, 2019
• Company
  Oyster Point Pharma, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This Indemnification Agreement (this “Agreement”) is dated as of , 2019 and is between Oyster Point Pharma, Inc., a Delaware corporation (the “Company”), and [insert name of indemnitee] (“Indemnitee”).

OYSTER POINT PHARMA, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT

Change in Control and Severance Agreement • October 4th, 2019 • Oyster Point Pharma, Inc. • Biological products, (no disgnostic substances) • New Jersey

• Contract Type
  Change in Control and Severance Agreement
• Filed
  October 4th, 2019
• Company
  Oyster Point Pharma, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New Jersey

This Change in Control and Severance Agreement (the “Agreement”) is made between Oyster Point Pharma, Inc. (the “Company”) and ________ (the “Executive”), effective as of _________________, 2019 (the “Effective Date”).

OYSTER POINT PHARMA, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT February 15, 2019

Investor Rights Agreement • October 4th, 2019 • Oyster Point Pharma, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Investor Rights Agreement
• Filed
  October 4th, 2019
• Company
  Oyster Point Pharma, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This Amended and Restated Investor Rights Agreement (this “Agreement”) is dated as of February 15, 2019, and is between Oyster Point Pharma, Inc., a Delaware corporation (the “Company”), and the persons and entities listed on Exhibit A (each, an “Investor” and collectively, the “Investors”).